<DOC>
	<DOCNO>NCT00653341</DOCNO>
	<brief_summary>The primary objective study compare percentage subject reach target HbA1c level ( &lt; = 7.0 % endpoint ) experience symptomatic nocturnal hypoglycemia treatment insulin glargine NPH human insulin .</brief_summary>
	<brief_title>Effect Insulin Glargine Insulin Naïve Subjects With Type 2 Diabetes Oral Hypoglycemic Agent ( )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Insulin naïve subject type 2 diabetes treat oral hypoglycemic agent Body mass index 26 40 kg/m2 HbA1c 7.5 % 10.0 % Fasting plasma glucose &gt; 7.8 mmol/L fast Cpeptide &gt; =0.25 nmol/L</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>insulin naive</keyword>
</DOC>